Common Contracts
4 similar Purchase Agreement contracts by Aileron Therapeutics Inc, Dare Bioscience, Inc., Marker Therapeutics, Inc., Trevi Therapeutics, Inc.
PURCHASE AGREEMENTPurchase Agreement • October 21st, 2024 • Dare Bioscience, Inc. • Pharmaceutical preparations • Illinois
THIS PURCHASE AGREEMENT (this “Agreement”), dated as of October 21, 2024, is made by and between DARÉ BIOSCIENCE, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
PURCHASE AGREEMENTPurchase Agreement • December 13th, 2022 • Marker Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS PURCHASE AGREEMENT (the "Agreement"), dated as of December 12, 2022, is made by and between MARKER THERAPEUTICS, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the "Investor").
PURCHASE AGREEMENTPurchase Agreement • June 21st, 2021 • Trevi Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of June 18, 2021, is made by and between TREVI THERAPEUTICS, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.
PURCHASE AGREEMENTPurchase Agreement • September 22nd, 2020 • Aileron Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of September 21, 2020, by and between AILERON THERAPEUTICS, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.
